Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Treatment for chronic daily headache by using auxiliary and alternative methods

Full Text:


Chronic daily headache (CDH) is one of the top 10 causes of adult disability and one of the 5 most common causes of female disability. To treat patients with CDH is one of the most difficult tasks in neurological practice. Difficulties in managing patients with CHD are associated with the high prevalence of comorbid mental disorders, analgesic abuse, pain syndromes at another site, and misconceptions of a patient about his/her disease. A combination of drug and non-drug therapies is the mainstay of the current approach to treating patients with CDH. Standard, alternative, and auxiliary therapies are identified. The paper describes different types of current auxiliary and alternative therapy used in the world’s leading headache centers and clinics. It describes experience with cerebrolysin used as auxiliary and alternative pharmacotherapies for CDH.

About the Authors

V. A. Golovacheva
Department of Nervous System Diseases and Neurosurgery, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia 11, Rossolimo St., Moscow 119021
Russian Federation

V. A. Parfenov
Department of Nervous System Diseases and Neurosurgery, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia 11, Rossolimo St., Moscow 119021
Russian Federation

V. V. Zakharov
Department of Nervous System Diseases and Neurosurgery, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia 11, Rossolimo St., Moscow 119021
Russian Federation


1. Halker RB, Hastriter EV, Dodick DW. Chronic daily headache: an evidence-based and systematic approach to a challenging problem. Neurology. 2011 Feb 15;76(7 Suppl 2):S37–43. doi: 10.1212/WNL.0b013e31820d5f32.

2. Silberstein S. Chronic daily headache. J Am Osteopath Assoc. 2005 Apr;105(4 Suppl 2):23S–29S.

3. Pascual J, Colar R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001 Dec;5(6):529–36.

4. Stovner LJ, Hangen K, Jensen R, et al. The global burden of headache: a documentation f headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007 Mar;27(3):193–210.

5. Nappi G, Perrotta A, Rossi P, Sandrini G. Chronic daily headache. Expert Rev Neurother. 2008 Mar;8(3):361–84. doi: 10.1586/14737175.8.3.361.

6. Kavuk I, Yavus A, Cetindere U, et al. Epidemiology of chronic daily headache. Eur J Med Res. 2003 Jun 30;8(6):236–40.

7. Maizels M. The patient with daily headaches. Am Fam Physician. 2004 Dec 15;70(12):2299–306.

8. Gaul C, Visscher CM, Bhola R, et al. Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache. J Headache Pain. 2011 Oct;12(5):511–9. doi: 10.1007/s10194-011- 0364-y. Epub 2011 Jul 21.

9. Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci. 2007 May;28 Suppl 2:S70–7.

10. Johnson CJ. Management of chronic daily headache: challenges in clinical practice. John Hopkins Advanced Studies in Medicine. Available at: ASIM_6_9C_pJohnson.pdf

11. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol. 2009 Sep;16(9):968–81. doi: 10.1111/j.1468-1331.2009.02748.x.

12. Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tensiontype headache – Report of an EFNS task force. Eur J Neurol. 2010 Nov;17(11):1318–25. doi: 10.1111/j.1468-1331.2010.03070.x.

13. Evers S, Jensen R; European Federation of Neurological Societies. Treatment of medication overuse headache – guideline of the EFNS headache panel. Eur J Neurol. 2011 Sep;18(9):1115–21. doi: 10.1111/j.1468-1331.2011.03497.x.

14. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. JAMA. 1998 Nov 11;280(18):1569–75.

15. Hä ussermann D. Increased confidence in natural therapies. Deutsch Arztebl. 1997;94:1857–8.

16. Sun-Edelstein C, Mauskop A. Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache. 2011 Mar;51(3):469–83. doi: 10.1111/j.1526- 4610.2011.01846.x.

17. Gaul C, EIsmann R, Schmidt T, et al. Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia. 2009 Oct;29(10):1069–78. doi: 10.1111/j.1468-2982.2009.01841.x. Epub 2009 Apr 2.

18. Gunreben-Stempfle B, Griessinger N, Lang E, et al. Effectiveness of an intensive multidisciplinary headache treatment program. Headache. 2009 Jul;49(7):990–1000. doi: 10.1111/j.1526-4610.2009.01448.x. Epub 2009 May 15.

19. Grazzi L, Andrasik F, D’Amico D, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: Outcome at 3 years. Headache. 2002 Jun;42(6):483–90.

20. Zeeberg P, Olesen J, Jensen R. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia. 2005 Dec;25(12):1159–67.

21. Milton J. Psychoanalysis and cognitive behavior therapy – rival paradigms or common ground? Int J Psychoanal. 2001 Jun;82 (Pt 3):431–47.

22. Wallasch TM, Kropp P. Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain. 2012 Oct;13(7):521–9. doi: 10.1007/s10194-012-0469-y. Epub 2012 Jul 12.

23. Holroyd KA, Drew JB. Behavioral approaches to the treatment of migraine. Semin Neurol. 2006 Apr;26(2):199–207.

24. Данилов АБ, Данилов АлБ. Управление болью. Биопсихосоциальный подход. Москва: АММ ПРЕСС; 2012. 568 с. [Danilov AB, Danilov AlB. Upravlenie bol'yu. Biopsikhosotsial'nyi podkhod [Management of pain. The biopsychosocial approach]. Moscow: AMM PRESS; 2012. 568 p.]

25. Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: Behavioral and physical treatments. US Headache Consortium 2000. Available at: s/gl0089.pdf

26. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standarts Subcommittee of the American Academy of Neurology. Neurology. 2000 Sep 26;55(6):754–62.

27. Табеева ГР, Яхно НН. Мигрень. Москва: ГЭОТАР-Медиа; 2011. 624 с. [Tabeeva GR, Yakhno NN. Migren' [Migraine]. Moscow: GEOTAR-Media; 2011. 624 p.]

28. Артеменко АР, Куренков АЛ. Хроническая мигрень. Москва: АБВ-пресс; 2012. 488 с. [Artemenko AR, Kurenkov AL. Khronicheskaya migren' [Chronic Migraine]. Moscow: ABV-press; 2012. 488 p.]

29. Biondi D. Physical treatments for headache: A structured review. Headache. 2005 Jun;45(6):738–46.

30. Blau JN, MacGregor EA. Migraine and the neck. Headache. 1994 Feb;34(2):88–90.

31. Tfelt-Hansen P, Lous I, Olesen J. Prevalence and significance of muscle tenderness during common migraine attacks. Headache. 1981 Mar;21(2):49–54.

32. Fricton J, Velly A, Ouyang W, Look JO. Does exercise therapy improve headache? A systematic review with meta-analysis. Curr Pain Headache Rep. 2009 Dec;13(6):413–9.

33. Pothmann R, Danesch U. Migraine prevention in children and adolescents: Results of an open study with a special butterbur root extract. Headache. 2005 Mar;45(3):196–203.

34. Oelkers-Ax R, Leins A, Parzer P, et al. Butterbur root extract and music therapy in the prevention of childhood migraine: An explorative study. Eur J Pain. 2008 Apr;12(3):301–13. Epub 2007 Jul 30.

35. Чутко ЛС, Сурушкина СЮ, Рожкова АВ и соавт. Астенические расстройства и когнитивные нарушения у пациентов с головной болью напряжения. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;(5):25–9. [Chutko LS, Surushkina SYu, Rozhkova AV i soavt. Asthenic disorders and cognitive impairment in patients with tension headache. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;(5):25–9. (In Russ.)].

36. Осипова ВВ. Головная боль напряжения: практическое руководство для врачей. Москва: ОГГИ; 2009. 40 с. [Osipova VV. Golovnaya bol' napryazheniya: prakticheskoe rukovodstvo dlya vrachei [Tension headache: a practical manual for doctors]. Moscow: OGGI; 2009. 40 p.]

37. Чутко ЛС, Рожкова АВ, Сидоренко ВА и др. Синдром эмоционального выгорания: качество жизни и фармакотерапия. Психиатрия и психофармакотерапия им. П.Б. Ганнушкина. 2012;(6):61–64.

38. Nash JM, Thebarge RW. Understanding psychological stress, its biological processes, and impact on primary headache. Headache. 2006 Oct;46(9):1377–86.

39. Beghi E, Bussone G, D’Amico D, et al. Headache, anxiety and depressive disorders: the HADAS study. J Headache Pain. 2010 Apr;11(2):141–50. doi: 10.1007/s10194-010- 0187-2. Epub 2010 Jan 27.

40. Blugeot A, Rivat C, Bouvier E, et al. Vulnerability to depression: from brain europlasticity to identification of biomarkers. J Neurosci. 2011 Sep 7;31(36):12889–99. doi: 10.1523/JNEUROSCI.1309-11.2011.

41. Massart R, Mongeau R, Lanfumey L, et al. Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2485–94. doi: 10.1098/rstb.2012.0212.

42. Царенко ДМ. Клинико-психопатологические особенности когнитивных нарушений при расстройствах тревожно-депрессивного спектра. Автореф. дисс. … канд. мед. наук. 2012. [Tsarenko DM. Klinikopsikhopatologicheskie osobennosti kognitivnykh narushenii pri rasstroistvakh trevozhno-depressivnogo spektra. Avtoref. diss. … kand. med. nauk. [Clinical and psychopathological features of cognitive impairment in disorders of anxiety and depressive spectrum. Autoref. Diss. ... cand. med. sci.] 2012. (In Russ.)] .

43. Калын ЯБ, Сафарова ТП, Шешенин ВС и др. Сравнительная эффективность и безопасность антидепрессивной моно- и мультимодальной терапии у пожилых больных депрессией (опыт клинического применения в геронтопсихиатрическом стационаре). Журнал неврологии и психиатрии им. С.С. Корсакова. 2014;(6):20–9. [Kalyn YaB, Safarova TP, Sheshenin VS, et al. Comparative efficacy and safety and the safety of antidepressant mono- and multimodal therapy in elderly patients with depression (clinical experience in inpatient gerontopsychiatric). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;(6):20–9. (In Russ.)].

44. Пантелеева ГП, Артюх ВВ, Крылова ЕС и др. Оптимизации психофармакотерапии эндогенных депрессий с помощью препарата Церебролизин. Психиатрия и психофармакотерапия им. П.Б. Ганнушкина 2012;(1):24–30.


For citations:

Golovacheva V.A., Parfenov V.A., Zakharov V.V. Treatment for chronic daily headache by using auxiliary and alternative methods. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(2):35-41. (In Russ.)

Views: 1011

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)